Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

Etanercept 6 Adalimumab 6 Infliximab 5 tocilizumab 3 golimumab 3 Tumor Necrosis Factor Inhibitors 3 tofacitinib 2 Rituximab 2 Certolizumab Pegol 2 Surveys and Questionnaires 1 Standard of Care 1 Practice Guidelines as Topic 1 Phlebotomy 1 Observation 1 Methods 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 Dietary Fiber 1 CT-P13 1 Antirheumatic Agents 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Arthritis, Rheumatoid × Abatacept × Clear all

NCT04529902 2021-11-23

DREAM

Brigham and Women's Hospital

63,013 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡